Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass

Diabetes
Jean ButeauDomenico Accili

Abstract

The glucoincretin hormone glucagon-like peptide-1 (GLP-1) increases pancreatic beta-cell proliferation and survival through sequential activation of the epidermal growth factor receptor (EGFR), phosphatidylinositol-3 kinase (PI 3-kinase), and Akt. We investigated the role of transcription factor FoxO1 in the proliferative and antiapoptotic actions of GLP-1 in beta-cells. GLP-1 inhibited FoxO1 through phosphorylation-dependent nuclear exclusion in pancreatic beta (INS832/13) cells. The effect of GLP-1 was suppressed by inhibitors of EGFR (AG1478) and PI 3-kinase (LY294002). In contrast, LY294002 but not AG1478 suppressed insulin-induced FoxO1 phosphorylation. Expression of constitutively nuclear FoxO1 in beta-cells prevented the proliferative and antiapoptotic actions of GLP-1 in cultured beta-cells and the increase in pancreatic beta-cell mass in response to Exendin4 in transgenic mice. Gene expression and chromatin immunoprecipitation assays demonstrated that GLP-1 increases pancreatic and duodenal homeobox gene-1 and Foxa2 expression and inhibits FoxO1 binding to both promoters. We propose that FoxO1 mediates the pleiotropic effects of the glucoincretin hormone on cell proliferation and survival.

References

Nov 24, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·G J Kops, B M Burgering
Jun 1, 2000·Endocrinology·S Bonner-Weir
Feb 13, 2001·Endocrinology·D J Drucker
Jul 13, 2002·The Journal of Pathology·Susan Bonner-Weir, Arun Sharma
Oct 24, 2002·The Journal of Biological Chemistry·Christian E WredeChristopher J Rhodes
Nov 1, 2002·The Journal of Biological Chemistry·Yazhou LiDaniel J Drucker
Dec 7, 2002·Diabetes/metabolism Research and Reviews·Jens Juul Holst
Apr 20, 2004·Diabetologia·J ButeauM Prentki
Sep 17, 2004·The Journal of Clinical Investigation·Rohit N KulkarniC Ronald Kahn
Jan 27, 2005·Science's STKE : Signal Transduction Knowledge Environment·George G Holz, Oleg G Chepurny
Sep 13, 2005·Cell Metabolism·Yukari Ido KitamuraDomenico Accili

❮ Previous
Next ❯

Citations

Apr 9, 2008·Oncogene·D N GrossM J Birnbaum
Aug 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rhonda D WidemanTimothy J Kieffer
Oct 13, 2009·Diabetes, Obesity & Metabolism·Yanmei LiuMichele Solimena
Oct 13, 2009·Diabetes, Obesity & Metabolism·C TalchaiD Accili
Dec 17, 2008·Pharmacological Reviews·Wook Kim, Josephine M Egan
Nov 30, 2012·American Journal of Physiology. Endocrinology and Metabolism·Zhenhua DongZhenqi Liu
May 12, 2012·International Journal of Endocrinology·Elena TarabraMichael Khan
Jan 4, 2007·The Journal of Clinical Investigation·Daniel J Drucker
Oct 8, 2011·Molecular Endocrinology·Shuen-Ing TschenAnil Bhushan
Jan 22, 2009·The Tohoku Journal of Experimental Medicine·Peng LinXinguo Hou
Apr 3, 2007·Diabetes·Laura C AlonsoAdolfo Garcia-Ocaña
Jun 12, 2008·Diabetes·Woo-Jin SongMehboob A Hussain
Jun 6, 2013·Mediators of Inflammation·Alessandra PudduFabrizio Montecucco
Jul 22, 2014·BioMed Research International·Genovefa D KolovouSophie Mavrogeni
May 7, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jeremy PettusSteven Edelman
Feb 1, 2007·Current Opinion in Organ Transplantation·Michael F Crutchlow, Doris A Stoffers
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity·Benedikt Aulinger, David D'Alessio
Jan 15, 2014·Journal of Cellular Biochemistry·Shiying ShaoYan Yang
Oct 13, 2012·Revista española de geriatría y gerontología·Giulia ParoniAlberto Pilotto
Oct 22, 2013·Metabolism: Clinical and Experimental·Young-Sun Lee, Hee-Sook Jun
Sep 1, 2011·Diabetes Research and Clinical Practice·Silke A SchäferKonstantinos Kantartzis
Dec 15, 2015·Current Opinion in Lipidology·Kerry-Anne RyeBlake J Cochran
Dec 1, 2015·International Journal of Biological Macromolecules·Yingnv GaoYu Ou
Jun 23, 2009·Trends in Endocrinology and Metabolism : TEM·Lynda Elghazi, Ernesto Bernal-Mizrachi
May 3, 2008·Molecular and Cellular Endocrinology·Neil A HanleyTimo Otonkoski
Dec 7, 2007·Current Opinion in Cell Biology·Sangeeta DhawanAnil Bhushan
May 15, 2007·Gastroenterology·Laurie L Baggio, Daniel J Drucker
Feb 20, 2007·Pharmacology & Therapeutics·Máire E Doyle, Josephine M Egan
Oct 9, 2007·Diabetes, Obesity & Metabolism·J Buteau, D Accili
Nov 3, 2010·Annals of the New York Academy of Sciences·Jeremy A Lavine, Alan D Attie
Jun 12, 2013·Journal of Internal Medicine·B Thorens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.